No abstract available
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Drug Discovery / methods
-
Drug Discovery / trends*
-
Fusion Proteins, bcr-abl / antagonists & inhibitors
-
Fusion Proteins, bcr-abl / genetics
-
Fusion Proteins, bcr-abl / metabolism
-
Genome, Human / genetics*
-
Genomics / trends
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Neoplasms / drug therapy*
-
Neoplasms / genetics*
-
Piperazines / pharmacology
-
Piperazines / therapeutic use
-
Precision Medicine / trends
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl